Fiera Capital (Canada)
AGIO icon

Fiera Capital (Canada)’s Agios Pharmaceuticals AGIO Stock Holding History

Fiera Capital (Canada)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-48,697
Closed -$2.51M – 657
2017
Q2 		$2.51M Sell
48,697
-5,741
-11% -$294K 0.01% 370
2017
Q1 		$3.18M Sell
54,438
-3,177
-6% -$152K 0.02% 346
2016
Q4 		$2.4M Sell
57,615
-11,107
-16% -$583K 0.01% 438
2016
Q3 		$3.63M Sell
68,722
-162,965
-70% -$7.1M 0.02% 362
2016
Q2 		$9.71M Buy
+231,687
New +$11.4M 0.05% 240

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fiera Capital (Canada)'s AGIO Position: Q3 2017 in Review

Fiera Capital (Canada) sold out of Agios Pharmaceuticals (AGIO) in Q3 2017, closing a stake of 48,697 shares — an estimated $2.51M sold.

Fiera Capital (Canada) first reported a position in AGIO in Q2 2016 and held it in 5 quarters. The position peaked at $9.71M in Q2 2016. 171 funds tracked by Wall St. Rank hold AGIO as of Q3 2017.

  • Fiera Capital (Canada) reported no remaining Agios Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 48,697 Agios Pharmaceuticals shares in Q3 2017, an estimated $2.51M.
  • Fiera Capital (Canada) first reported a position in Agios Pharmaceuticals in Q2 2016 and held it in 5 quarters.
  • Fiera Capital (Canada)'s Agios Pharmaceuticals position peaked at $9.71M in Q2 2016.
  • 171 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2017, filed 13 Nov 2017.